A new biotechnology startup in Northern Ireland is making significant progress in the field of regenerative medicine. LifeCellsNI, a health technology startup based in Derry, has successfully raised £590000 in pre seed funding to establish the region’s first licensed stem cell storage facility. The project represents an important step forward for life sciences infrastructure in Northern Ireland and could support new medical research and advanced therapies in the future.
The investment will allow the company to build a modern cryogenic storage and laboratory processing hub designed to safely collect and preserve stem cells for families, healthcare organizations, and research institutions. By creating this facility locally, LifeCellsNI aims to solve a major problem currently faced by patients and researchers across the region.
A Major Gap in Regional Healthcare Infrastructure
Northern Ireland currently lacks a dedicated facility for regulated long term stem cell storage. As a result, biological materials such as cord blood stem cells often need to be shipped to laboratories in mainland United Kingdom for processing and storage.
This process can create logistical challenges, higher costs, and regulatory complications for healthcare providers and researchers. Without local infrastructure, it becomes more difficult for hospitals and universities to participate fully in advanced therapy research and regenerative medicine programs.
LifeCellsNI plans to address this issue by building a local facility capable of securely storing stem cells under strict regulatory oversight. The company’s facility will operate under governance frameworks designed to meet official licensing standards for handling human tissues.
The presence of a local stem cell bank could significantly improve access to advanced medical technologies and research opportunities in Northern Ireland.
Investment Led by Angel Syndicate
The pre seed investment round was led by AMP Angel Syndicate, with additional funding support coming from Co Fund III, which is managed by Clarendon Fund Managers.
This funding will help LifeCellsNI build the necessary infrastructure for its cryogenic storage systems and laboratory processing facilities. Construction of specialized cleanrooms is already underway, and the company plans to complete commissioning and validation milestones before launching operations in 2026.
The investment reflects growing interest in biotechnology innovation across Northern Ireland and demonstrates confidence in the potential of the region’s life sciences sector.
Supporting Families and Medical Research
LifeCellsNI aims to provide services that support both individual families and the broader healthcare ecosystem.
One of the company’s primary services will be the storage of cord blood stem cells. Cord blood collected during childbirth contains valuable stem cells that may be used in future treatments for certain medical conditions. Families can choose to preserve these cells as a potential medical resource for their children or relatives.
In addition to family storage services, LifeCellsNI will also offer laboratory access and biobanking services for healthcare providers, universities, and biotechnology companies.
These services will include secure cryogenic storage, laboratory processing in controlled environments, and reliable cold chain logistics to ensure that biological materials are handled safely and compliantly.
The company also plans to offer contingency biobanking services that allow healthcare organizations to store biological materials without building their own infrastructure.
Ethical and Regulatory Protections
Because stem cell storage involves sensitive biological materials, strict ethical and regulatory safeguards are required. LifeCellsNI has designed its facility to ensure clear separation between personal biological samples owned by families and materials used for research or commercial purposes.
This governance structure helps protect consent, ownership rights, and privacy for individuals who choose to store their stem cells.
Maintaining these ethical standards will be essential for building public trust and ensuring that the facility operates responsibly within the healthcare system.
Expanding the Life Sciences Sector
The launch of a stem cell bank could also strengthen Northern Ireland’s position within the global life sciences industry.
Advanced therapies such as regenerative medicine, cell therapy, and tissue engineering rely heavily on access to high quality biological materials and specialized storage infrastructure. Without these capabilities, research institutions and biotechnology companies may struggle to conduct cutting edge research locally.
By creating this missing infrastructure, LifeCellsNI hopes to support new scientific collaborations and attract additional investment in the region’s health technology sector.
The company has already received support from several innovation organizations and incubator programs that help develop early stage startups in the region.
Looking Ahead
LifeCellsNI plans to launch its facility in April 2026, with stem cell storage operations expected to begin later in the year.
If successful, the company could become a central hub for stem cell storage and regenerative medicine research across Northern Ireland and the wider island of Ireland.
As healthcare technologies continue to advance, the ability to store and process stem cells safely may play a critical role in developing new treatments for diseases and improving patient outcomes.
For Northern Ireland, the emergence of LifeCellsNI represents not only a new startup success story but also a step toward building stronger infrastructure for future medical innovation.
Leave a Reply